Shen-Yung Kao

Title: Shen-Yung Kao: Innovator in Transdermal Delivery Systems

Introduction

Shen-Yung Kao is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal delivery systems. With a total of 3 patents, his work focuses on innovative methods for delivering therapeutic agents effectively.

Latest Patents

One of Shen-Yung Kao's latest patents is a transdermal delivery system containing methylphenidate or its salts. This system is designed to deliver a therapeutically effective amount of methylphenidate to treat neurological conditions such as Attention Deficit Disorder (ADD) and Attention Deficit/Hyperactivity Disorder (ADHD). The patent outlines methods for creating kits that include the transdermal delivery system, enhancing the accessibility and usability of this treatment option.

Career Highlights

Throughout his career, Shen-Yung Kao has worked with various companies, including Taho Pharmaceuticals Ltd. and Lee, Catherine. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.

Collaborations

Shen-Yung Kao has collaborated with notable individuals in his field, including Taijung Wu and Catherine Lee. These partnerships have likely enriched his research and development efforts, leading to impactful innovations.

Conclusion

Shen-Yung Kao is a distinguished inventor whose work in transdermal delivery systems has the potential to improve treatment options for individuals with neurological conditions. His contributions to the field are noteworthy and reflect his commitment to advancing pharmaceutical technology.